ストックスクリーナーアプリを入手
0.4349
6.05%
0.0248
アフターアワーズ：
.45
0.0151
+3.47%
前日終値:
$0.4101
開ける：
$0.41
24時間の取引高:
6.23M
Relative Volume:
1.79
時価総額：
$50.60M
収益：
-
当期純損益:
$-119.76M
株価収益率:
-0.3221
EPS:
-1.35
ネットキャッシュフロー:
$-55.17M
1週間 パフォーマンス:
-15.77%
1か月 パフォーマンス:
-9.77%
6か月 パフォーマンス:
-94.35%
1年 パフォーマンス:
-92.65%
1日の値動き範囲:
$0.40
$0.4504
1週間の範囲:
$0.3952
$0.5162
52週間の値動き範囲:
$0.3952
$10.62
Applied Therapeutics Inc Stock (APLT) Company Profile
名前
Applied Therapeutics Inc
セクター
電話
212-220-9226
住所
545 FIFTH AVENUE, SUITE 1400, NEW YORK, NY
APLT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
APLT
Applied Therapeutics Inc
|
0.4349 | 50.60M | 0 | -119.76M | -55.17M | -1.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.62 | 121.88B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.45 | 62.69B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
555.11 | 33.86B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
235.74 | 30.51B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
238.51 | 25.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Applied Therapeutics Inc Stock (APLT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-23 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2024-12-02 | ダウングレード | UBS | Buy → Neutral |
| 2024-11-29 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-07-31 | 開始されました | William Blair | Outperform |
| 2024-03-26 | 開始されました | RBC Capital Mkts | Outperform |
| 2024-02-22 | 開始されました | Leerink Partners | Outperform |
| 2022-01-04 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2021-08-27 | ダウングレード | Goldman | Neutral → Sell |
| 2021-06-25 | 再開されました | Goldman | Neutral |
| 2020-10-08 | 開始されました | Truist | Buy |
| 2020-04-22 | 開始されました | Goldman | Buy |
| 2020-02-27 | 開始されました | Barclays | Overweight |
| 2019-06-10 | 開始されました | Citigroup | Buy |
| 2019-06-10 | 開始されました | Cowen | Outperform |
| 2019-06-10 | 開始されました | Robert W. Baird | Outperform |
すべてを表示
Applied Therapeutics Inc (APLT) 最新ニュース
APLT stock touches 52-week low at $0.42 amid sharp annual decline - Investing.com
Charles Schwab Investment Management Inc. Has $600,000 Position in Applied Therapeutics, Inc. (NASDAQ:APLT) - Defense World
Applied Therapeutics Delays Yearly Report Filing - TipRanks
Applied Therapeutics files Form 12b-25 with SEC - TipRanks
Applied Therapeutics Files Form 12b-25 with the Securities and Exchange Commission - GlobeNewswire
Applied Therapeutics Requests SEC Extension: What This Means for 2024 Financial Results - Stock Titan
146,900 Shares in Applied Therapeutics, Inc. (NASDAQ:APLT) Purchased by Swiss National Bank - Defense World
Shareholders of Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights – APLT - ACCESS Newswire
Lost Money on Applied Therapeutics, Inc.(APLT)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - ACCESS Newswire
Applied Therapeutics, Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights – APLT - ACCESS Newswire
APLT LAWSUIT ALERT: Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ACCESS Newswire
Applied Therapeutics appoints new Chief Regulatory Officer By Investing.com - Investing.com South Africa
Applied Therapeutics Appoints Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer - citybiz
APLT DEADLINE ALERT: Applied Therapeutics Investors have until February 18 before Expiration of the Class Action DeadlineContact BFA Law if You Lost Money - Louisiana First News
Applied Therapeutics Names Todd Baumgartner As Chief Regulatory Officer - Nasdaq
Applied Therapeutics appoints new Chief Regulatory Officer - Investing.com
Applied Therapeutics Strengthens Drug Approval Push With 12-Time FDA Success Veteran - Stock Titan
Brokerages Set Applied Therapeutics, Inc. (NASDAQ:APLT) Price Target at $6.10 - MarketBeat
Applied Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your RightsAPLT - ACCESS Newswire
Applied Therapeutics, Inc. (NASDAQ:APLT) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
APPLIED THERAPEUTICS Earnings Preview: Recent $APLT Insider Trading, Hedge Fund Activity, and More - Nasdaq
A look into Applied Therapeutics Inc (APLT)’s deeper side - SETE News
Applied Therapeutics Inc (APLT) Announces Year-End 2023 Financia - GuruFocus.com
40,300 Shares in Applied Therapeutics, Inc. (NASDAQ:APLT) Purchased by Private Advisor Group LLC - Defense World
Shareholders of Applied Therapeutics, Inc. Should Contact The Gr - GuruFocus.com
Applied Therapeutics, Inc. Class Action: Levi & Korsinsky Remind - GuruFocus.com
Applied therapeutics COO Constantine Chinoporos sells $196 in stock - Investing.com India
Applied Therapeutics (APLT) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat
Applied therapeutics’ interim CEO sells shares worth $6,380 - Investing.com India
Applied Therapeutics chief medical officer sells shares worth $4,561 - Investing.com India
Applied Therapeutics chief medical officer sells shares worth $4,561 By Investing.com - Investing.com UK
Monitoring Applied Therapeutics Inc (APLT) after recent insider movements - Knox Daily
APLT Deadline: APLT Purchasers Have Opportunity to Lead Applied Therapeutics, Inc. Securities Fraud Lawsuit - GuruFocus.com
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Applied Therapeutics - GuruFocus.com
Levi & Korsinsky Notifies Shareholders of Applied Therapeutics, Inc. (APLT) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
Class Action Filed Against Applied Therapeutics, Inc. (APLT)February 18, 2025 Deadline to JoinContact Levi & Korsinsky - ACCESS Newswire
APLT stock touches 52-week low at $0.49 amid sharp annual decline - Investing.com India
APLT stock touches 52-week low at $0.49 amid sharp annual decline By Investing.com - Investing.com South Africa
Applied Therapeutics (APLT) to Release Earnings on Wednesday - Defense World
Shareholders that lost money on Applied Therapeutics, Inc.(APLT) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
Applied Therapeutics (APLT) Projected to Post Earnings on Wednesday - MarketBeat
Applied Therapeutics, Inc. Investigated Regarding Potential Securities Law ViolationsContact Levi & Korsinsky for DetailsAPLT - ACCESS Newswire
Market Fluctuations Drive Mega-Cap, Large-Cap, Mid-Cap, and Small-Cap Stocks in Wild Movements Today - HPBL
ATTENTION Applied Therapeutics, Inc. Investors: You May Have Been Affected by FraudContact Levi & Korsinsky to Discuss Your Rights - ACCESS Newswire
APLT stock touches 52-week low at $0.54 amid sharp annual decline By Investing.com - Investing.com South Africa
APLT stock touches 52-week low at $0.54 amid sharp annual decline - Investing.com
Applied Therapeutics Inc (APLT) At $0.58 Is Well Worth Your Time - Stocks Register
Applied Therapeutics, Inc. (NASDAQ:APLT) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
2025-02-18 | Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics, Inc. LawsuitAPLT | NDAQ:APLT | Press Release - Stockhouse Publishing
Shareholders of Applied Therapeutics, Inc. Should Contact The Gross Law Firm Before February 18, 2025 to Discuss Your RightsAPLT - PR Newswire
Applied Therapeutics, Inc. Sued for Securities Law - GlobeNewswire
Applied Therapeutics Inc (APLT) 財務データ
収益
当期純利益
現金流量
EPS
Applied Therapeutics Inc (APLT) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Funtleyder Leslie D. | See Remarks |
Mar 04 '25 |
Sale |
0.44 |
14,502 |
6,381 |
390,459 |
| Chinoporos Constantine | See Remarks |
Mar 04 '25 |
Sale |
0.44 |
447 |
197 |
271,436 |
| Funtleyder Leslie D. | See Remarks |
Feb 06 '25 |
Sale |
0.61 |
22,950 |
14,000 |
404,961 |
| Perfetti Riccardo | Chief Medical Officer |
Feb 06 '25 |
Sale |
0.61 |
86,078 |
52,508 |
900,775 |
| Chinoporos Constantine | See Remarks |
Feb 06 '25 |
Sale |
0.61 |
28,117 |
17,151 |
271,883 |
| Funtleyder Leslie D. | Chief Financial Officer |
Aug 22 '24 |
Sale |
5.83 |
13,530 |
78,880 |
277,911 |
| Perfetti Riccardo | Chief Medical Officer |
Aug 22 '24 |
Sale |
5.83 |
22,681 |
132,230 |
986,853 |
| Shendelman Shoshana | President and CEO |
Aug 13 '24 |
Sale |
6.18 |
357,423 |
2,208,874 |
4,810,430 |
| Shendelman Shoshana | President and CEO |
Aug 12 '24 |
Sale |
5.98 |
300,000 |
1,794,000 |
5,167,853 |
| Shendelman Shoshana | President and CEO |
Aug 14 '24 |
Sale |
5.93 |
119,591 |
709,175 |
4,690,839 |
3.01%
大文字化:
|
ボリューム (24 時間):